References
- HendersonSA development in social psychiatry. The systematic study of social bondsJ Nerv Ment Dis1980168263697354308
- WeissmanMMThe assessment of social functioning. A review of techniquesArch Gen Psychiatry19753233573651115576
- WeissmanMMKlermanGLPaykelESTreatment effects on the social adjustment of depressed patientsArch Gen Psychiatry19743067717784832185
- PaykelESWeissmanMMPrusoffBASocial maladjustment and severity of depressionCompr Psychiatry1978192121128630854
- HaysRDWellsKBSherboumeCDFunctioning and well-being outcomes of patients with depression compared with chronic general medical illnessesArch Gen Psychiatry199552111197811158
- LeaderJBKleinDNSocial adjustment in dysthymia, double depression and episodic major depressionJ Affect Disord1996372391101
- TseWSBondAJThe impact of depression on social skillsJ Nerv Ment Dis2004192426026815060399
- KatonWThe impact of depression on workplace functioning and disability costsAm J Manag Care200915Suppl 11S322S32720088628
- StefosGBauwensFStanerLPsychosocial predictors of major affective recurrences in bipolar disorder: A 4-year longitudinal study of patients on prophylactic treatmentActa Psychiatr Scand19969364204268831857
- DourishCTGorkaZWilliamsARIversenSDPotential influence of social support in a rodent model of depressionJ Psychopharmacol198938
- Jenks KettmannJDAltmaierEMSocial support and depression among bone marrow transplant patientsJ Health Psychol2008131394618086716
- SymisterPFriendRThe influence of social support and problematic support on optimism and depression in chronic illness: A prospective study evaluating self-esteem as a mediatorHealth Psychol200322212312912683732
- GaoYMacDonaldDCollinsKDAlaghehbandanRChenYRole of social support in the relationship between sexually transmitted infection and depression among young women in CanadaJ Epidemiol201020431331820551580
- CarlssonACorrodiHFuxeKHökfeltTEffect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramineEur J Pharmacol1969543573665786359
- HealyDMcMonagleTThe enhancement of social functioning as a therapeutic principle in the management of depressionJ Psychopharmacol199711Suppl 4S25S319438230
- CharneyDSMonoamine dysfunction and the pathophysiology and treatment of depressionJ Clin Psychiatry199859Suppl 1411149818625
- LeonardBENoradrenaline in basic models of depressionEur Neuropsychopharmacol19977Suppl 1S11S169169306
- BymasterFPMcNamaraRKTranPVNew approaches to developing antidepressants by enhancing monoaminergic neurotransmissionExpert Opin Investig Drugs2003124531543
- NeumeisterATryptophan depletion, serotonin, and depression: Where do we stand?Psychopharmacol Bull20033749911515131521
- KlimekVSchenckJEHanHDopaminergic abnormalities in amygdaloid nuclei in major depression: A postmortem studyBiol Psychiatry200252774074812372665
- NuttDJRelationship of neurotransmitters to the symptoms of major depressive disorderJ Clin Psychiatry200869Suppl E14718494537
- KasperSPailGMilnacipran: A unique antidepressant?Neuropsychiatr Dis Treat.20106Suppl 1233120856597
- TseWSBondAJDifference in serotonergic and noradrenergic regulation of human social behavioursPsychopharmacology (Berl)2002159221622111862352
- TseWSBondAJReboxetine promotes social bonding in healthy volunteersJ Psychopharmacol200317218919512870566
- TseWSBondAJNoradrenaline might enhance assertive human social behaviours: An investigation in a flatmate relationshipPharmacopsychiatry200639517517916944408
- BechPSocial functioning: Should it become an endpoint in trials of antidepressants?CNS Drugs200519431332415813645
- DalyEJTrivediMHWisniewskiSRHealth-related quality of life in depression: A STAR*D reportAnn Clin Psychiatry2010221435520196982
- WeissmanMMOlfsonMGameroffMJA comparison of three scales for assessing social functioning in primary careAm J Psychiatry2001158346046611229989
- BoscMDubiniAPolinVDevelopment and validation of a social functioning scale, the Social Adaptation Self-evaluation ScaleEur Neuropsychopharmacol19977Suppl 1S57S709169311
- BoscMAssessment of social functioning in depressionCompr Psychiatry2000411636910646621
- HealyDReboxetine: Its effects as measured by the Social Adaptation Self-evaluation ScaleActa Psychiatr Scand2000402Suppl4551
- WareJEJrSherbourneCDThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionMed Care19923064734831593914
- WeissmanMMBothwellSAssessment of social adjustment by patient self-reportArch Gen Psychiatry197633911111115962494
- DubiniABoscMPolinVDo noradrenaline and serotonin differentially affect social motivation and behaviour?Eur Neuropsychopharmacol19977Suppl 1S49S559169310
- DubiniABoscMPolinVNoradrenaline-selective versus serotonin- selective antidepressant therapy: Differential effects on social functioningJ Psychopharmacol199711Suppl 4S17S239438229
- MassanaJMöllerHJBurrowsGDMontenegroRMReboxetine: A double-blind comparison with fluoxetine in major depressive disorderInt Clin Psychopharmacol1999142738010220121
- KellerMRole of serotonin and noradrenaline in social dysfunction: A review of data on reboxetine and the Social Adaptation Self-evaluation Scale (SASS)Gen Hosp Psychiatry2001231151911226552
- PapakostasGINelsonJCKasperSMöllerHJA meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorderEur Neuropsychopharmacol200818212212717719752
- GorensteinCAndradeLMorenoRAArtesRSocial adjustment in depressed patients treated with venlafaxine and amitriptylineInt Clin Psychopharmacol200217417117512131600
- MbayaPSafety and efficacy of high dose of venlafaxine XL in treatment resistant major depressionHum Psychopharmacol200217733533912415551
- PjrekEWilleitMPraschak-RiederNTreatment of seasonal affective disorder with duloxetine: An open-label studyPharmacopsychiatry200841310010518484551
- StahlSMGradyMMMoretCBrileyMSNRIs: Their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressantsCNS Spectr200510973274716142213
- UedaNYoshimuraRHoujoTEffects of milnacipran on social adaptation in patients with depressionRinshyo Seisin Yakuri2008112273279
- IshidaTInadaYKudoMStudy on the clinical efficacy of milnacipran by using the Social Adaptation Self-evaluation ScaleJpn J Clin Psychopharmacol2010137783
- MöllerHJAre all antidepressants the same?J Clin Psychiatry200061Suppl 62428
- UedaHTakashiHMayumiKEffect of paroxetine and milnacipran on social adaptation in depressed patients (in Japanese)Presented at the 15th Japan Society for Clinical and Neuropsychiatric Pharmacology meeting2005Tokyo
- YoshimuraRTreatment in depression for achieving remission – from drug selection to returning to workplaceJpn J Clin Psychopharmacol2008116213220